Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

BUY
N/A
122,414 Added 25.59%
600,788 $5.83 Million
Q1 2021

May 17, 2021

SELL
N/A
-177,367 Reduced 27.05%
478,374 $5.14 Million
Q4 2020

Feb 16, 2021

BUY
N/A
283,340 Added 76.08%
655,741 $9.65 Million
Q3 2020

Nov 16, 2020

SELL
N/A
-305,422 Reduced 45.06%
372,401 $5.29 Million
Q2 2020

Aug 14, 2020

BUY
N/A
200,119 Added 41.89%
677,823 $5.48 Million
Q1 2020

May 15, 2020

BUY
N/A
477,704 New
477,704 $1.93 Million

About Trillium Therapeutics Inc.


  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.